|
A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.
|
Apr 2012
|
Ann Hematol.
|
aplastic anemia
|
|
A retrospective study of paroxysmal nocturnal hemoglobinuria in pediatric and adolescent patients
|
Mar 2017
|
Blood Cells Mol Dis
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the Nort
|
Aug 2020
|
Pediatric Blood & Cancer
|
aplastic anemia, pediatric
|
|
A systematic modeling study on the pathogenic role of p38 MAPK activation in myelodysplastic syndromes
|
Feb 2012
|
Mol Biosyst
|
myelodysplastic syndromes (MDS)
|
|
A systematic review of patient reported outcomes in phase II or III clinical trials of myelodysplastic syndromes and acute myeloid leukemia
|
Jun 2018
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.
|
Jun 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Acquired aplastic anemia in children
|
Oct 2013
|
Pediatr Clin North Am
|
aplastic anemia
|
|
Acquired Aplastic Anemia: What Have We Learned and What Is in the Horizon?
|
Jun 2018
|
Pediatr Clin North Am.
|
aplastic anemia
|
|
Activin Receptor II Ligand Traps: New Treatment Paradigm for Low-Risk MDS
|
Jun 2019
|
Current Hematologic Malignancy Report
|
myelodysplastic syndromes (MDS)
|
|
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
|
Apr 2023
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
